FULCRUM THERAPEUTICS INC's ticker is FULC and the CUSIP is 359616109. A total of 106 filers reported holding FULCRUM THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.08 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $203,756 | +52.0% | 30,186 | 0.0% | 0.01% | +50.0% |
| Q3 2023 | $134,026 | +34.5% | 30,186 | 0.0% | 0.00% | +33.3% |
| Q2 2023 | $99,614 | +15.8% | 30,186 | 0.0% | 0.00% | +50.0% |
| Q1 2023 | $86,030 | -60.9% | 30,186 | 0.0% | 0.00% | -71.4% |
| Q4 2022 | $219,754 | -9.9% | 30,186 | 0.0% | 0.01% | -12.5% |
| Q3 2022 | $244,000 | +64.9% | 30,186 | 0.0% | 0.01% | +60.0% |
| Q2 2022 | $148,000 | -82.2% | 30,186 | -14.2% | 0.01% | -78.3% |
| Q1 2022 | $832,000 | +33.8% | 35,186 | 0.0% | 0.02% | +35.3% |
| Q4 2021 | $622,000 | -40.9% | 35,186 | -5.8% | 0.02% | -45.2% |
| Q3 2021 | $1,053,000 | +169.3% | 37,341 | 0.0% | 0.03% | +158.3% |
| Q2 2021 | $391,000 | -11.1% | 37,341 | 0.0% | 0.01% | -14.3% |
| Q1 2021 | $440,000 | +0.7% | 37,341 | 0.0% | 0.01% | -6.7% |
| Q4 2020 | $437,000 | +151.1% | 37,341 | +69.9% | 0.02% | +114.3% |
| Q3 2020 | $174,000 | -56.7% | 21,984 | 0.0% | 0.01% | -56.2% |
| Q2 2020 | $402,000 | -19.8% | 21,984 | -47.6% | 0.02% | -30.4% |
| Q1 2020 | $501,000 | – | 41,984 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP IV, LLC | 2,343,154 | $10,403,604 | 3.92% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 5,718,881 | $25,391,832 | 1.37% |
| COWEN AND COMPANY, LLC | 4,308,359 | $19,129,113 | 1.34% |
| RA Capital Management | 11,609,704 | $51,547,086 | 1.02% |
| RTW INVESTMENTS, LP | 5,818,804 | $25,835,490 | 0.54% |
| Acuitas Investments, LLC | 134,811 | $598,561 | 0.35% |
| Simplify Asset Management Inc. | 570,519 | $2,533,104 | 0.29% |
| Vivo Capital, LLC | 520,000 | $2,308,800 | 0.25% |
| BRANDYWINE MANAGERS, LLC | 26,127 | $116,004 | 0.20% |
| DENALI ADVISORS LLC | 70,600 | $313,464 | 0.11% |